Search
Return to previous page-
rSP-D for the treatment of inflammatory lung diseases
Opportunity: 240
rSP-D is a novel biological entity with enormous potential as a therapeutic for inflammatory respiratory diseases. It is a recombinant fragment of human surfactant protein D (SP-D) that is readily produced using E. coli. Opportunity 240
CAN'T FIND WHAT YOU'RE LOOKING FOR?
We are constantly adding new opportunities and may be working on something of interest to you. If you are looking for something specific please contact us or register for email alerts for new opportunities as they become available.